reproduced verbatim): Protein-protein interaction is a key method by which biological events are regulated. We have developed a new method for measuring protein interactions that overcomes limitations of previous assays. This method, which we call Bioluminescence Resonance Energy Transfer (BRET), uses a bioluminescent luciferase that is genetically fused to one candidate protein, and an acceptor fluorophore fused to another protein of interest. If the two candidate proteins interact so as to bring the luciferase and fluorophore in proximity, resonance energy transfer can occur. This interaction is measure as a shift in the color of the bioluminescence emission. BRET will be particularly useful for testing protein interactions within the native cells, especially with integral membrane proteins or proteins targeted to specific organelles. We will apply this method to our topic of primary research interest, """"""""biological clocks,"""""""" and to general applications for the determination of protein-protein interactions within cells and organelles. Biological clocks are important to human physiology. For example, psychiatric and medical studies have shown that circadian rhythmicity is involved in some forms of depressive illness, """"""""jet lag,"""""""" drug tolerance/efficacy, memory, and insomnia. Therefore, understanding the biochemical mechanism of circadian clocks may lead to procedures which will be useful in the diagnosis and treatment of disorders that are relevant to sleep, mental health, and pharmacology. Despite the importance of clocked phenomena, however, clues to the nature of the underlying biochemical mechanism are only just beginning to emerge. Recent investigations report that protein interactions play key roles in circadian clock mechanisms in eukaryotes. Using well-characterized interacting proteins and proteins encoded by clock genes, we will use the BRET system to 1) test whether results obtained by previous methods for assessing protein interactions can be confirmed with the BRET method, and 2) assay clock protein interactions in situ over the daily cycle to appraise temporal control of protein interaction.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21GM059984-02
Application #
6387007
Study Section
Special Emphasis Panel (ZRG1-MDCN-6 (01))
Program Officer
Tompkins, Laurie
Project Start
2000-05-01
Project End
2003-04-30
Budget Start
2001-05-01
Budget End
2003-04-30
Support Year
2
Fiscal Year
2001
Total Cost
$113,625
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Borrok, M Jack; Zhu, Yimin; Forest, Katrina T et al. (2009) Structure-based design of a periplasmic binding protein antagonist that prevents domain closure. ACS Chem Biol 4:447-56